Social Dominance, Gender, and Cardiovascular Reactivity

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005522
First received: May 25, 2000
Last updated: November 10, 2005
Last verified: October 2005
  Purpose

To examine biopsychosocial processes that might contribute to the associations among social dominance, gender, and cardiovascular reactivity,.


Condition
Cardiovascular Diseases
Heart Diseases
Coronary Disease

Study Type: Observational
Study Design: Observational Model: Natural History

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: May 1998
Estimated Study Completion Date: April 2004
Detailed Description:

BACKGROUND:

Social dominance, the tendency to exercise social influence and control, has been positively associated with coronary heart disease (CHD) risk among males, independent of biomedical risk factors and hostility. Exposure to dominant others behaviors also has been associated with elevated CHD risk. For females, submissiveness and a constellation of psychosocial behaviors opposite to urgency and competitiveness have been associated with increased risk for cardiovascular disease (CVD). The studies extend a growing literature concerning the central role of social relationships in health and illness and they test a theoretical model that addresses why social relationships and interpersonally-oriented person variables such as dominance may have differing consequences for the physical well-being of men and women.

DESIGN NARRATIVE:

The three studies were designed to test a social-contextual model of dominance and cardiovascular stress reactivity (CVR) that synthesized and elaborated earlier models in order to account for (1) cardiovascular consequences of exposure to dominant others and (2) differences in dominant men's and women's cardiovascular responses to social interactions. Because of the disproportionately high rates of CVD among Black Americans, both Black and white men and women were included in the studies.

Using a laboratory social interaction paradigm, study 1 refined and validated a coding system designed to assess dominant and hostile behaviors during dyadic social interaction. Study 2 examined two factors proposed to account for differences in dominant men's and women's cardiovascular responses to social interaction: (1) explicit role demands regarding dominance expression (i.e., the degree to which situations provided clear and salient cues regarding expected and acceptable behavior) and (2) gender composition of the dyad (i.e., same sex versus opposite sex). These two factors were manipulated independently while unacquainted, healthy young adult men and women participated in task-oriented dyadic discussions designed to activate motives to influence; cardiovascular responses were measured during the discussions and preceding rests. Study 3, a secondary analysis of data collected in study 2, examined associations between CVR and exposure to others' dominance. The aforementioned behavioral coding system was used to assess behavioral dominance observed in study 2 and path analytic techniques were used to model associations among CVR, one's own and one's partner's trait and behavioral dominance, gender, and situational factors.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005522

Sponsors and Collaborators
Investigators
Investigator: Tamara Newton Boston University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00005522     History of Changes
Other Study ID Numbers: 5049
Study First Received: May 25, 2000
Last Updated: November 10, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Coronary Disease
Coronary Artery Disease
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases

ClinicalTrials.gov processed this record on July 20, 2014